SMTNL1
gene geneOn this page
Also known as CHASM
Summary
SMTNL1 (smoothelin like 1, HGNC:32394) is a protein-coding gene on chromosome 11q12.1, encoding Smoothelin-like protein 1 (A8MU46). Plays a role in the regulation of contractile properties of both striated and smooth muscles.
The protein encoded by this gene is involved in the contraction of both striated and smooth muscle. During pregnancy, the encoded protein interacts with progesterone receptor to attenuate the expression of contractile and metabolic proteins.
Source: NCBI Gene 219537 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 84 total
- MANE Select transcript:
NM_001105565
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:32394 |
| Approved symbol | SMTNL1 |
| Name | smoothelin like 1 |
| Location | 11q12.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | CHASM |
| Ensembl gene | ENSG00000214872 |
| Ensembl biotype | protein_coding |
| OMIM | 613664 |
| Entrez | 219537 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000527972
RefSeq mRNA: 1 — MANE Select: NM_001105565
NM_001105565
CCDS: CCDS44599
Canonical transcript exons
ENST00000527972 — 8 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001536715 | 57546501 | 57546652 |
| ENSE00001536717 | 57546233 | 57546347 |
| ENSE00001536718 | 57545881 | 57546036 |
| ENSE00001536721 | 57543869 | 57543920 |
| ENSE00001536723 | 57543624 | 57543756 |
| ENSE00002154135 | 57549968 | 57550272 |
| ENSE00003558129 | 57542641 | 57543374 |
| ENSE00003928755 | 57537595 | 57537642 |
Expression profiles
Bgee: expression breadth ubiquitous, 164 present calls, max score 99.13.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 1.4870 / max 633.4361, expressed in 56 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 114277 | 1.0936 | 46 |
| 114276 | 0.3934 | 39 |
Top tissues by expression
252 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 99.13 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 98.11 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 98.06 | gold quality |
| vastus lateralis | UBERON:0001379 | 98.00 | gold quality |
| biceps brachii | UBERON:0001507 | 97.98 | gold quality |
| quadriceps femoris | UBERON:0001377 | 97.85 | gold quality |
| body of tongue | UBERON:0011876 | 97.77 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 97.28 | gold quality |
| gastrocnemius | UBERON:0001388 | 96.97 | gold quality |
| deltoid | UBERON:0001476 | 96.73 | gold quality |
| tibialis anterior | UBERON:0001385 | 95.72 | silver quality |
| muscle of leg | UBERON:0001383 | 95.42 | gold quality |
| muscle tissue | UBERON:0002385 | 89.62 | gold quality |
| tongue | UBERON:0001723 | 86.85 | gold quality |
| pharyngeal mucosa | UBERON:0000355 | 77.55 | gold quality |
| buccal mucosa cell | CL:0002336 | 76.69 | gold quality |
| superior surface of tongue | UBERON:0007371 | 75.99 | gold quality |
| trabecular bone tissue | UBERON:0002483 | 70.64 | gold quality |
| pancreatic ductal cell | CL:0002079 | 68.56 | silver quality |
| upper arm skin | UBERON:0004263 | 67.96 | gold quality |
| monocyte | CL:0000576 | 67.84 | gold quality |
| sperm | CL:0000019 | 67.65 | gold quality |
| leukocyte | CL:0000738 | 66.91 | gold quality |
| myocardium | UBERON:0002349 | 66.90 | gold quality |
| mucosa of stomach | UBERON:0001199 | 65.72 | gold quality |
| oral cavity | UBERON:0000167 | 65.64 | gold quality |
| apex of heart | UBERON:0002098 | 65.04 | gold quality |
| blood | UBERON:0000178 | 64.96 | gold quality |
| granulocyte | CL:0000094 | 64.36 | gold quality |
| cortical plate | UBERON:0005343 | 63.70 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.42 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
4 targeting SMTNL1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6762-3P | 99.66 | 66.94 | 1188 |
| HSA-MIR-1290 | 99.59 | 69.90 | 2079 |
| HSA-MIR-6081 | 99.48 | 66.07 | 1446 |
| HSA-MIR-6836-3P | 97.08 | 64.99 | 712 |
Literature-anchored findings (GeneRIF, showing 3)
- The Smtnl1 proximal promoter enhances expression up to 8-fold in smooth muscle cells and a second activating region lays 500 bp further upstream. (PMID:21352594)
- Pregnancy promotes switching of skeletal muscle to a glycolytic phenotype through the smoothelin-like protein 1 transcriptional cofactor. (PMID:26048986)
- Smoothelin-Like Protein 1 Regulates Development and Metabolic Transformation of Skeletal Muscle in Hyperthyroidism. (PMID:34675885)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Smtnl1 | ENSMUSG00000027077 |
| rattus_norvegicus | Smtnl1 | ENSRNOG00000007516 |
| drosophila_melanogaster | Ehbp1 | FBGN0034180 |
Paralogs (7): ASPM (ENSG00000066279), MICALL1 (ENSG00000100139), EHBP1 (ENSG00000115504), GAS2 (ENSG00000148935), MICALL2 (ENSG00000164877), EHBP1L1 (ENSG00000173442), GAS2L1 (ENSG00000185340)
Protein
Protein identifiers
Smoothelin-like protein 1 — A8MU46 (reviewed: A8MU46)
All UniProt accessions (1): A8MU46
UniProt curated annotations — full annotation on UniProt →
Function. Plays a role in the regulation of contractile properties of both striated and smooth muscles. When unphosphorylated, may inhibit myosin dephosphorylation. Phosphorylation at Ser-299 reduces this inhibitory activity.
Subunit / interactions. Interacts with PPP1R12A.
Subcellular location. Cytoplasm. Myofibril. Sarcomere. I band. M line. Nucleus.
Tissue specificity. Expressed in striated muscles, specifically in type 2a fibers (at protein level).
Post-translational modifications. Maximal phosphorylation of Ser-336 correlates with maximal relaxation of aorta in response to acetylcholine.
Similarity. Belongs to the smoothelin family.
RefSeq proteins (1): NP_001099035* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001715 | CH_dom | Domain |
| IPR036872 | CH_dom_sf | Homologous_superfamily |
| IPR050540 | F-actin_Monoox_Mical | Family |
Pfam: PF00307
UniProt features (14 total): compositionally biased region 8, region of interest 2, chain 1, domain 1, modified residue 1, coiled-coil region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A8MU46-F1 | 56.70 | 0.23 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 336
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 75 (showing top):
GOBP_CIRCULATORY_SYSTEM_PROCESS, GOBP_REGULATION_OF_ANATOMICAL_STRUCTURE_SIZE, GOBP_ANIMAL_ORGAN_MORPHOGENESIS, GOBP_POSITIVE_REGULATION_OF_VASOCONSTRICTION, GOBP_MUSCLE_STRUCTURE_DEVELOPMENT, GOBP_MUSCLE_ORGAN_MORPHOGENESIS, GOBP_REGULATION_OF_SYSTEM_PROCESS, GOBP_REGULATION_OF_VASOCONSTRICTION, GOBP_VASCULAR_PROCESS_IN_CIRCULATORY_SYSTEM, GOBP_REGULATION_OF_BLOOD_CIRCULATION, GOBP_RESPONSE_TO_ACTIVITY, GOCC_I_BAND, GOBP_POSITIVE_REGULATION_OF_MULTICELLULAR_ORGANISMAL_PROCESS, GOCC_M_BAND, GOCC_A_BAND
GO Biological Process (6): response to xenobiotic stimulus (GO:0009410), response to activity (GO:0014823), vasoconstriction (GO:0042310), negative regulation of DNA-templated transcription (GO:0045892), positive regulation of vasoconstriction (GO:0045907), muscle organ morphogenesis (GO:0048644)
GO Molecular Function (6): calmodulin binding (GO:0005516), tropomyosin binding (GO:0005523), protein phosphatase 1 binding (GO:0008157), CH domain binding (GO:0051401), disordered domain specific binding (GO:0097718), protein binding (GO:0005515)
GO Cellular Component (6): nucleus (GO:0005634), cytoplasm (GO:0005737), M band (GO:0031430), I band (GO:0031674), contractile muscle fiber (GO:0043292), myofibril (GO:0030016)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| protein domain specific binding | 2 |
| response to chemical | 1 |
| response to stimulus | 1 |
| blood vessel diameter maintenance | 1 |
| DNA-templated transcription | 1 |
| regulation of DNA-templated transcription | 1 |
| negative regulation of RNA biosynthetic process | 1 |
| regulation of vasoconstriction | 1 |
| vasoconstriction | 1 |
| positive regulation of multicellular organismal process | 1 |
| muscle organ development | 1 |
| animal organ morphogenesis | 1 |
| protein binding | 1 |
| cytoskeletal protein binding | 1 |
| protein phosphatase binding | 1 |
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular anatomical structure | 1 |
| A band | 1 |
| sarcomere | 1 |
| cytoplasm | 1 |
| intracellular membraneless organelle | 1 |
| supramolecular fiber | 1 |
| contractile muscle fiber | 1 |
Protein interactions and networks
STRING
580 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SMTNL1 | PPP1R12A | O14974 | 803 |
| SMTNL1 | PRKG1 | P14619 | 797 |
| SMTNL1 | RNF208 | Q9H0X6 | 520 |
| SMTNL1 | FASTKD3 | Q14CZ7 | 481 |
| SMTNL1 | SMTN | P53814 | 432 |
| SMTNL1 | CTNND1 | O60716 | 409 |
| SMTNL1 | PGR | P06401 | 398 |
| SMTNL1 | PDLIM3 | Q53GG5 | 392 |
| SMTNL1 | KRTAP19-1 | Q8IUB9 | 370 |
| SMTNL1 | TNFRSF10D | Q9UBN6 | 348 |
| SMTNL1 | SMPX | Q9UHP9 | 348 |
| SMTNL1 | AKNAD1 | Q5T1N1 | 336 |
| SMTNL1 | KDM6B | O15054 | 318 |
| SMTNL1 | LRCH4 | O75427 | 317 |
| SMTNL1 | C2CD2L | O14523 | 315 |
IntAct
5 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SMTNL1 | H1-10 | psi-mi:“MI:0915”(physical association) | 0.400 |
| SMTNL1 | SH3GL1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| ADAMTS13 | C2CD4B | psi-mi:“MI:0914”(association) | 0.350 |
| CEP250 | SMTNL1 | psi-mi:“MI:0914”(association) | 0.350 |
ESM2 similar proteins: A0A1B0GR13, A0A571BEE2, A8MU46, E9Q9K5, F1QBY1, O01949, O02828, O43493, P05229, P06719, P08855, P09346, P10156, P12036, P12305, P12675, P20810, P20811, P27321, P29172, P35662, P35663, P38978, P51125, P54938, P57786, P70486, P82179, Q02752, Q05018, Q05019, Q09202, Q09355, Q13061, Q14093, Q27450, Q28092, Q28820, Q54IN6, Q55H65
Diamond homologs: A5D7D1, A8MU46, D3ZEN0, D3ZHV2, D3ZQL6, D4A1F2, E1BBG2, E7F9T0, F1MF74, F1QH17, F1QWK4, F1RA39, F6QZ15, G3MWR8, G3V7L1, L7UZ85, M9MRD1, O13728, O15020, O43707, O76329, O88990, O94851, O97592, P05094, P05095, P11277, P11530, P11531, P11532, P11533, P12814, P15508, P18091, P20111, P30427, P35609, P46939, P53814, P57780
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
84 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 81 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1188 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:57543369:G:GT | donor_gain | 1.0000 |
| 11:57543371:GGCA:G | donor_gain | 1.0000 |
| 11:57543372:GCAG:G | donor_gain | 1.0000 |
| 11:57543375:G:GG | donor_gain | 1.0000 |
| 11:57543389:A:T | donor_gain | 1.0000 |
| 11:57543425:G:GT | donor_gain | 1.0000 |
| 11:57543447:G:GG | donor_gain | 1.0000 |
| 11:57543457:A:T | donor_gain | 1.0000 |
| 11:57543753:ACAGG:A | donor_loss | 1.0000 |
| 11:57543754:CAGG:C | donor_loss | 1.0000 |
| 11:57543757:G:GA | donor_loss | 1.0000 |
| 11:57545880:GT:G | acceptor_gain | 1.0000 |
| 11:57545880:GTGA:G | acceptor_gain | 1.0000 |
| 11:57546344:CGAGG:C | donor_loss | 1.0000 |
| 11:57546345:GAGG:G | donor_loss | 1.0000 |
| 11:57546346:AGG:A | donor_loss | 1.0000 |
| 11:57546348:GTGG:G | donor_loss | 1.0000 |
| 11:57546349:T:G | donor_loss | 1.0000 |
| 11:57546489:T:TA | acceptor_gain | 1.0000 |
| 11:57546493:T:A | acceptor_gain | 1.0000 |
| 11:57546498:TAGCA:T | acceptor_loss | 1.0000 |
| 11:57546499:A:AG | acceptor_gain | 1.0000 |
| 11:57546499:AGCAT:A | acceptor_gain | 1.0000 |
| 11:57546500:G:GG | acceptor_gain | 1.0000 |
| 11:57546500:GC:G | acceptor_gain | 1.0000 |
| 11:57546500:GCAT:G | acceptor_gain | 1.0000 |
| 11:57546500:GCATG:G | acceptor_gain | 1.0000 |
| 11:57546648:GCAGA:G | donor_gain | 1.0000 |
| 11:57546650:AGAG:A | donor_loss | 1.0000 |
| 11:57546651:GA:G | donor_gain | 1.0000 |
AlphaMissense
3248 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:57546531:T:A | W407R | 1.000 |
| 11:57546531:T:C | W407R | 1.000 |
| 11:57546318:T:A | W387R | 0.999 |
| 11:57546318:T:C | W387R | 0.999 |
| 11:57546320:G:C | W387C | 0.999 |
| 11:57546320:G:T | W387C | 0.999 |
| 11:57546323:C:G | C388W | 0.999 |
| 11:57546528:A:C | S406R | 0.999 |
| 11:57546530:C:A | S406R | 0.999 |
| 11:57546530:C:G | S406R | 0.999 |
| 11:57546532:G:C | W407S | 0.999 |
| 11:57546533:G:C | W407C | 0.999 |
| 11:57546533:G:T | W407C | 0.999 |
| 11:57546541:G:A | G410D | 0.999 |
| 11:57546541:G:T | G410V | 0.999 |
| 11:57546554:T:G | C414W | 0.999 |
| 11:57546556:C:A | A415D | 0.999 |
| 11:57546570:T:C | F420L | 0.999 |
| 11:57546572:C:A | F420L | 0.999 |
| 11:57546572:C:G | F420L | 0.999 |
| 11:57546626:C:A | N438K | 0.999 |
| 11:57546626:C:G | N438K | 0.999 |
| 11:57546639:T:C | F443L | 0.999 |
| 11:57546640:T:C | F443S | 0.999 |
| 11:57546641:C:A | F443L | 0.999 |
| 11:57546641:C:G | F443L | 0.999 |
| 11:57550042:T:A | V472D | 0.999 |
| 11:57550063:T:C | L479P | 0.999 |
| 11:57550075:T:C | L483P | 0.999 |
| 11:57546310:T:C | L384P | 0.998 |
dbSNP variants (sampled 300 via entrez): RS1000044799 (11:57547623 G>A), RS1000223759 (11:57537355 C>T), RS1000338301 (11:57548391 T>C), RS1000588555 (11:57535744 C>T), RS1000645034 (11:57542327 C>A,T), RS1000946820 (11:57546712 C>T), RS1001074642 (11:57540128 G>C), RS1001125420 (11:57540498 A>G), RS1001176559 (11:57536570 T>C), RS1001587410 (11:57546429 T>C,G), RS1001589403 (11:57547032 G>A,C), RS1001638517 (11:57549518 TTTTAA>T), RS1001773191 (11:57540869 C>A,T), RS1001929934 (11:57548531 G>A,T), RS1002162364 (11:57542033 C>T)
Disease associations
OMIM: gene MIM:613664 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST006946_6 | Worry too long after an embarrassing experience | 1.000000e-11 |
| GCST006951_1 | Feeling hurt | 2.000000e-08 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0009589 | worry measurement |
| EFO:0009599 | feeling emotionally hurt measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| Acetaminophen | increases expression | 1 |
| Benzo(a)pyrene | affects methylation, decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.